Based on end-user, the vaccine research market has been segmented by public and private. The public segment will have significant market growth during the forecast period. In terms of geography, North America will present significant opportunities for market vendors due to factors such as the rising focus on immunization programs.
Vaccine Research Market: Major Growth Drivers
The vaccine research market report considers the following factors as major growth drivers during the forecast period:
- High prevalence of infectious diseases
- Rising focus on immunization programs
- Growing government support for vaccine development
Gain more insights into the global trends, drivers, and challenges impacting the future of the vaccine research market. Request a Free Sample Report Now!
Vaccine Research Market: Key Vendor Offerings
- Bavarian Nordic AS: The company offers vaccine research solutions that are used for clinical development on products that include MVA BN freeze dried, MVA BN RSV, ABNCoV2, TAEK VAC and MVA BN WEV, under the brand name of Bavarian Nordic.
- CSL Ltd: The company offers vaccine research solutions that are used to enhance the immune response of those particularly vulnerable to influenza such as children and older adults using cell-based technology and MF59 adjuvant immune booster, under the brand name of CSL.
- Emergent BioSolutions Inc: The company offers vaccine research solutions that help in achieving balance in the products that are developed through a pipeline comprising innovative vaccines and therapeutics that target diseases worldwide which include Vaxchora, AV7909, CHIKV VLP, and many more, under the brand name of Emergent BioSolutions.
Reasons to Buy Vaccine Research Market Report:
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will assist vaccine research market growth during the next five years
- Estimation of the vaccine research market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the vaccine research market across North America, Europe, APAC, South America, and MEA
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of vaccine research market vendors
Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!
Related Reports:
- Clinical Mass Spectrometry Market: The clinical mass spectrometry market has been segmented by end-user (healthcare facilities and pharma and biotech companies and research labs and institutes) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
- Single-use Bioprocessing System Market: The single-use bioprocessing system market has been segmented by product (bags and mixers, bioreactors and fermenters, filtration devices and sampling systems, bioprocess containers, and others), end-user (pharmaceutical companies, CROs and CMOs, biotechnology companies, and academic and research institutions), application (mAb production, vaccine production, plant cell cultivation, PSCTs, and others), and geography (North America, Europe, Asia, and ROW). Download Free Sample Report
Vaccine Research Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.08% |
Market growth 2021-2025 |
USD 11.93 billion |
Market structure |
Concentrated |
YoY growth (%) |
7.22 |
Regional analysis |
North America, Europe, APAC, South America, and MEA |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Canada, Germany, China, UK, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Bavarian Nordic AS, CSL Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., and Sanofi SA |
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article